Acute transverse myelitis in demyelinating disease of central nervous system digital illustration

Acute transverse myelitis in demyelinating disease of central nervous system Save


ICD-10 code: G37.3

Disease category: G37: Other demyelinating diseases of central nervous system

Understanding Acute Transverse Myelitis in Demyelinating Diseases of the Central Nervous System

Acute transverse myelitis (ATM) is a rare neurological condition characterized by inflammation of the spinal cord. It is often seen in association with demyelinating diseases of the central nervous system (CNS) such as multiple sclerosis (MS), neuromyelitis optica (NMO), and acute disseminated encephalomyelitis (ADEM). ATM can occur suddenly, causing significant damage to the spinal cord and resulting in various neurological symptoms.

While the exact cause of ATM is still unknown, it is believed to be an autoimmune response triggered by an infection or an immune system malfunction. In demyelinating diseases, the immune system mistakenly attacks the protective covering of nerve fibers, known as myelin. When this occurs in the spinal cord, it leads to inflammation, disruption of nerve signals, and subsequent neurological symptoms.

The symptoms of ATM can vary depending on the location and extent of spinal cord damage. Common symptoms include sudden onset of back pain, weakness or paralysis in the limbs, bladder and bowel dysfunction, sensory abnormalities, and in severe cases, respiratory problems. Prompt medical attention is crucial to prevent further damage and to manage the symptoms effectively.

Diagnosing ATM involves a thorough physical examination, medical history review, and various diagnostic tests. These tests may include magnetic resonance imaging (MRI) of the spinal cord, cerebrospinal fluid analysis, and blood tests to rule out other possible causes of similar symptoms.

Although there is no specific treatment for ATM itself, managing the underlying demyelinating disease is key to controlling symptoms and preventing further episodes. Treatment options for demyelinating diseases often involve medications to suppress the immune system and reduce inflammation. Rehabilitation therapies, such as physical therapy and occupational therapy, may be recommended to improve mobility and functionality.

  1. ATM is a rare neurological condition associated with demyelinating diseases of the CNS.
  2. It is believed to be an autoimmune response triggered by an infection or immune system malfunction.
  3. Symptoms include back pain, limb weakness or paralysis, and sensory abnormalities.
  4. Diagnostic tests such as MRI and cerebrospinal fluid analysis help confirm the diagnosis.
  5. Treatment focuses on managing the underlying demyelinating disease.

In conclusion, acute transverse myelitis in demyelinating diseases of the central nervous system is a complex condition that requires timely diagnosis and appropriate management. If you experience any symptoms suggestive of ATM, it is important to seek medical attention promptly. Early intervention can significantly improve outcomes and enhance the quality of life for individuals affected by this condition.

Treatment of Acute transverse myelitis in demyelinating disease of central nervous system:

Understanding Treatment Options for Acute Transverse Myelitis in Demyelinating Disease of the Central Nervous System

Acute transverse myelitis (ATM) is a rare neurological condition that affects the spinal cord, causing inflammation and damage to the nerve fibers. It often occurs as a result of demyelinating diseases such as multiple sclerosis (MS) or neuromyelitis optica (NMO). Wh...

To see full information about treatment please Sign up or Log in